Method of administering bisphosphonates
US8052987B2 · kind B2 · utility
2Cited by
13References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2001 |
| Grant date | Nov 8, 2011 |
| Priority date | — |
| Expiry date | Oct 27, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/7053
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to bisphosphonates, in particular more potent N-bisphosphonates such as zoledronic acid and derivatives, and to methods of treatment using bisphosphonates. These bisphosphonates are used with satisfactory results for prolonged inhibition of bone resorption in conditions of abnormally increased bone turnover, e.g. osteoporosis, by intermittent administration, the periods between bisphosphonate administrations are longer than was previously considered appropriate, e.g. a dosing interval of at least about 6 months or less frequently.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.